Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: A randomised trial

被引:38
作者
Goodman, Anna
Davies, Christopher W. H.
机构
[1] Royal Berkshire Hosp NHS Trust, Dept Resp Med, Reading RG1 5AN, Berks, England
[2] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
关键词
pleurodesis; pleural effusions; palliative care; talc; sclerosant; malignancy;
D O I
10.1016/j.lungcan.2006.06.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Talc pleurodesis is commonly used in the palliative treatment of malignant pleural effusions but the shortest and most effective regime has not been determined. In particular, it is not clear when the intercostal drain should be removed following the insertion of sclerosant. We conducted a single-centre, randomised, open trial of drain removal. at 24 h versus 72 h following talc slurry pleurodesis. The primary outcome measure was success of pleurodesis (no recurrence of effusion on chest radiograph at 1-month follow-up) and secondary outcome measures included length of hospital. stay and mortality. We found no difference between recurrence of pleural effusion in those randomised to drain removal at 24 h and those randomised to drain removal at 72 h (p > 0.5). However, length of stay was significantly reduced when the chest drain was removed at 24 h (4 days versus 8 days; p < 0.01). Mortality did not differ between the two groups. We conclude that this shorter pleurodesis regime is safe and effective. (C) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 7 条
[1]  
ANTUNES G, 2003, THORAX S2, V58, P29, DOI DOI 10.1136/THORAX.58.SUPPL_2.II29
[2]   Predicting survival in patients with recurrent symptomatic malignant pleural effusions - An assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease [J].
Burrows, CM ;
Mathews, C ;
Colt, HG .
CHEST, 2000, 117 (01) :73-78
[3]   Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion [J].
Hsu, WH ;
Chiang, CD ;
Chen, CY ;
Kwan, PC ;
Hsu, JY .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (03) :187-191
[4]   Pleurodesis practice for malignant pleural effusions in five English-speaking countries - Survey of pulmonologists [J].
Lee, YCG ;
Baumann, MH ;
Maskell, NA ;
Waterer, GW ;
Eaton, TE ;
Davies, RJO ;
Heffner, JE ;
Light, RW .
CHEST, 2003, 124 (06) :2229-2238
[5]   SURVIVAL AND TALC PLEURODESIS IN METASTATIC PLEURAL CARCINOMA, REVISITED - REPORT OF 125 CASES [J].
SANCHEZARMENGOL, A ;
RODRIGUEZPANADERO, F .
CHEST, 1993, 104 (05) :1482-1485
[6]   Rapid pleurodesis for malignant pleural effusions [J].
Spiegler, PA ;
Hurewitz, AN ;
Groth, ML .
CHEST, 2003, 123 (06) :1895-1898
[7]   EFFICACY OF SHORT-TERM VERSUS LONG-TERM TUBE THORACOSTOMY DRAINAGE BEFORE TETRACYCLINE PLEURODESIS IN THE TREATMENT OF MALIGNANT PLEURAL EFFUSIONS [J].
VILLANUEVA, AG ;
GRAY, AW ;
SHAHIAN, DM ;
WILLIAMSON, WA ;
BEAMIS, JF .
THORAX, 1994, 49 (01) :23-25